+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Role of the endocannabinoid system in the control of mouse myometrium contractility during the menstrual cycle



Role of the endocannabinoid system in the control of mouse myometrium contractility during the menstrual cycle



Biochemical Pharmacology 124: 83-93



Cannabis and cannabinoids are known to affect female reproduction. However, the role of the endocannabinoid system in mouse uterine contractility in the dioestrus and oestrus phases has not been previously investigated. The present study aimed at filling this gap. Endocannabinoid (anandamide and 2-arachidonoylglycerol) levels were measured in mouse uterus at dioestrus and oestrus phases by liquid chromatography-mass spectrometry; quantitative reverse transcription-PCR and western blot were used to measured the expression of cannabinoid receptors and enzymes involved in the metabolism of endocannabinoids. Contractility was evaluated in vitro either on the spontaneous contractions or by stimulating the isolated uterus with exogenous spasmogens. The tissue concentrations of anandamide and 2-AG were reduced in the oestrus phase, compared to dioestrus. Uteri obtained in the dioestrus, but not oestrus, phase showed spontaneous phasic prostaglandin-mediated contractions that were reduced by ACEA (CB1 receptor agonist) and to a lower extent by JWH133 (CB2 receptor agonist). These inhibitory effects were counteracted by the corresponding selective antagonists. Neither ACEA nor JWH133 did affect the contractions induced by exogenous PGE2 in the uterus from the oestrus phase. The FAAH inhibitor JNJ1661010 and, to a lower extent, the MAGL inhibitor JZL184 also reduced spontaneous contractions. It is concluded that the endocannabinoid system undergoes to adaptive changes between the oestrus and dioestrus phases. CB1 and, to a lower extent, CB2 receptor activation results in selective inhibition of myometrial contractility, without un-specific relaxing effects on the smooth muscle. These results might be of interest for female marijuana smokers as well as for the design of novel tocolytic agents.

(PDF emailed within 0-6 h: $19.90)

Accession: 058791307

Download citation: RISBibTeXText

PMID: 27899300

DOI: 10.1016/j.bcp.2016.11.023


Related references

Role of the cellular membrane in the humoral control of the myometrium contractility. Fiziologicheskii Zhurnal SSSR Imeni I M Sechenova 58(11): 1737-1743, 1972

The role of the central nervous system in the control of the menstrual cycle of the rhesus monkey. Experimental Brain Research Suppl 3: 200-207, 1981

Endogenous opioid peptides in the control of the normal menstrual cycle and their possible role in athletic menstrual irregularities. Obstetrical & Gynecological Survey 44(10): 720-732, 1989

The role of emotion regulation in the experience of menstrual symptoms and perceived control over anxiety-related events across the menstrual cycle. Archives of Women's Mental Health 19(6): 1109-1117, 2016

Studies on the role of dopamine in uterine contractility. I. Concentration of serotonin, noradrenaline and dopamine in rat myometrium as a function of the cycle phase. Ginekologia Polska 47(4): 413-415, 1976

Endocannabinoid regulation in human endometrium across the menstrual cycle. Reproductive Sciences 22(1): 113-123, 2016

The emerging role of the endocannabinoid system in the sleep-wake cycle modulation. Central Nervous System Agents in Medicinal Chemistry 11(3): 189-196, 2012

Changes in the lactate dehydrogenase of the human myometrium during the menstrual cycle. Z Physiol Chem 351(7): 891-892, 1970

The endocannabinoid system and pivotal role of the CB2 receptor in mouse spermatogenesis. Proceedings of the National Academy of Sciences of the United States of America 106(27): 11131-6, 2009

The relationship between plasma levels of the endocannabinoid, anandamide, sex steroids, and gonadotrophins during the menstrual cycle. Fertility and Sterility 93(6): 1989-1996, 2010

Characterization of the endocannabinoid system, CB(1) receptor signalling and desensitization in human myometrium. British Journal of Pharmacology 164(5): 1479-1494, 2012

Steroids in human myometrium and in peripheral blood during the menstrual cycle. Fertility & Sterility 28(3): 351, 1977

Steroids in human myometrium and peripheral blood during the menstrual cycle. American Journal of Obstetrics and Gynecology 131(6): 628-631, 1978

Role of the endocannabinoid system in metabolic control. Current Opinion in Nephrology and Hypertension 17(1): 1-10, 2007

Leukotriene release by endometrium and myometrium throughout the menstrual cycle in dysmenorrhea and menorrhagia. Journal of Endocrinology 113(2): 291-296, 1987